Skip to content

Effect of resistance exercise on plasma interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha), knee extensor muscle strength and functional capacity in older women

Effect of resistance exercise on plasma interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha), knee extensor muscle strength and functional capacity in older women: a single-blind randomised controlled cross-over trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62824599
Enrollment
26
Registered
2009-12-08
Start date
2009-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee extensor muscle strength/functional capacity in older women Musculoskeletal Diseases

Interventions

The subjects will participate in a strength training programme three times a week, lasting 60-minute each session, for 10 weeks. Two major muscle groups (knee extensors and flexors) will both be train

Sponsors

National Council of Scientific and Technological Development (CNPq) (Brazil)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female 2. Community-dwelling 3. Aged equal to or higher than 65 years-old 4. Classified as pre-frail according to the phenotype

Exclusion criteria

Exclusion criteria: 1. Elderly previously submitted to orthopedic surgeries on lower limbs and/or with a history of fracture 2. Those whom were not able to walk without support 3. Carriers of neurological diseases 4. Those whom presented any type of inflammatory disease in an acute stage 5. Neoplasia in activity in the last five years 6. Those whom were using medication that affect largely the immunological system 7. Those whom presented cognitive impairments detectable by the Mini-Mental State Examination (MMSE)

Design outcomes

Primary

MeasureTime frame
Plasma levels of IL-6 and TNF-alpha measured by enzyme-linked immunosorbent assay. All primary and secondary outcomes will be assessed at baseline (before intervention), after intervention and 10 weeks post-intervention.

Secondary

MeasureTime frame
1. Static and isokinetic muscle strength of the knee extensors and flexors measured electronically by Byodex 3 Pro (Biodex Medical System, USA) 2. Functional capacity, measured by the 10-meter walk test and the Timed Up and Go test (TUG) 3. Clinical outcomes (pain, fatigue and self-perceived health) All primary and secondary outcomes will be assessed at baseline (before intervention), after intervention and 10 weeks post-intervention.

Countries

Brazil

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 31, 2026